Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Evonik-Expands-New-GM

More Like This

PR Newswire associated0

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

Business Wire associated0

Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

PR Newswire associated0

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

PR Newswire associated0

Cambrex Advances US and European Expansions

LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

WuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes Line